Session VII: Immune Checkpoint Inhibitors for NSCLC

Session Moderator(s)

• 

  Corey Langer, MD, FACP

  Abramson Cancer Center, Hospital of the University of Pennsylvania

Presenter(s)

• 

  Edward Garon, MD, MS

  University of California, Los Angeles
• 

  Marina Garassino, MD

  University of Chicago
• 

  Jamie Chaft, MD

  Memorial Sloan Kettering Cancer Center
• 

  Joel Neal, MD, PhD

  Stanford University Medical Center
• 

  Aaron Lisberg, MD

  University of California, Los Angeles

Presentations:

• 1:35 PM – 1:40 PM

  Welcome and Introduction; Pre-Session Audience Survey
  

  Chair: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania
• 1:40 PM – 2:00 PM

  Basics of Immunotherapy in NSCLC
  

  Speaker: Edward B. Garon, MD, MS – University of California, Los Angeles
• 2:00 PM – 2:20 PM

  Primacy of CPIs in Front-Line Management
  

  Speaker: Marina Garassino, MD – University of Chicago
• 2:20 PM – 2:27 PM

  Debate: Adjuvant vs Neoadjuvant CPIs in Resectable NSCLC? - Neoadjuvant
  

  Debate Speaker: Jamie E. Chaft, MD – Memorial Sloan Kettering Cancer Center
• 2:27 PM – 2:34 PM

  Debate: Adjuvant vs Neoadjuvant CPIs in Resectable NSCLC? - Adjuvant
  

  Debate Speaker: Joel W. Neal, MD, PhD – Stanford University Medical Center
• 2:34 PM – 2:40 PM

  Debate: Adjuvant vs Neoadjuvant CPIs in Resectable NSCLC? - Discussion
  

  Panelist: Jamie E. Chaft, MD – Memorial Sloan Kettering Cancer Center

  Panelist: Joel W. Neal, MD, PhD – Stanford University Medical Center
• 2:40 PM – 2:50 PM

  Debate: How to Handle PD-L1 > 50%: Use Pembrolizumab + Histology Specific Chemo v Use Pembrolizumab Alone - Use Pembrolizumab + Histology Specific Chemo
  

  Debate Speaker: Aaron Lisberg, MD – University of California, Los Angeles
• 2:50 PM – 3:00 PM

  Debate: How to Handle PD-L1 > 50%: Use Pembrolizumab + Histology Specific Chemo v Use Pembrolizumab Alone - Use Pembrolizumab Alone
  

  Debate Speaker: Edward B. Garon, MD, MS – University of California, Los Angeles
• 3:00 PM – 3:10 PM

  Debate: How to Handle PD-L1 > 50%: Discussion
  

  Panelist: Aaron Lisberg, MD – University of California, Los Angeles

  Panelist: Edward B. Garon, MD, MS – University of California, Los Angeles
• 3:10 PM – 3:30 PM

  Q&A; Post-Session Audience Survey
  

  Moderator: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania

  Panelist: Edward B. Garon, MD, MS – University of California, Los Angeles

  Panelist: Marina Garassino, MD – University of Chicago

  Panelist: Jamie E. Chaft, MD – Memorial Sloan Kettering Cancer Center

  Panelist: Joel W. Neal, MD, PhD – Stanford University Medical Center

  Panelist: Aaron Lisberg, MD – University of California, Los Angeles